Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells.
暂无分享,去创建一个
Christian Billard | R. Mohammad | D. Dauzonne | Ramzi M Mohammad | Daniel Dauzonne | Claire Quiney | Catherine Kern | Jean-Dominique Fourneron | Jean-Claude Izard | Jean-Pierre Kolb | J. Kolb | C. Billard | C. Kern | C. Quiney | J. Fourneron | J. Izard | D. Dauzonne*
[1] Jen-kun Lin,et al. Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrol , 1999, British journal of pharmacology.
[2] H. Sedlacek. Mechanisms of action of flavopiridol. , 2001, Critical reviews in oncology/hematology.
[3] M. Grever,et al. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. , 1998, Blood.
[4] E. Sausville,et al. Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol , 1998 .
[5] F. Mentz,et al. Comparative Antiproliferative and Apoptotic Effects of Resveratrol, ϵ-viniferin and Vine-shots Derived Polyphenols (Vineatrols) on Chronic B Lymphocytic Leukemia Cells and Normal Human Lymphocytes , 2002, Leukemia & lymphoma.
[6] F. Ross,et al. Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement. , 1990, Leukemia research.
[7] B. Gaston,et al. S-Nitrosylation of mitochondrial caspases , 2001, The Journal of cell biology.
[8] R. Greil,et al. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells , 2000, Cell Death and Differentiation.
[9] R A F MacLeod,et al. DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL) , 2002, Leukemia.
[10] R. Mohammad,et al. Analysis of resveratrol‐induced apoptosis in human B‐cell chronic leukaemia , 2002, British journal of haematology.
[11] John Calvin Reed,et al. Protein Kinase Inhibitors Flavopiridol and 7-hydroxy-staurosporine Down-regulate Antiapoptosis Proteins in B-cell Chronic Lymphocytic Leukemia , 2022 .
[12] D. Koop,et al. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. , 1999, Biochemical pharmacology.
[13] D. Geller,et al. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte , 1999, Hepatology.
[14] J Dörrie,et al. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. , 2001, Cancer research.
[15] S. Seki,et al. Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells , 1998, Hepatology.
[16] F. Sigaux,et al. Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line , 2000, Leukemia.
[17] Ko Jp. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. , 2000 .
[18] G. Kong,et al. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. , 1999, Cancer letters.
[19] M. Taylor,et al. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation. , 1991, Leukemia research.
[20] F. Sigaux,et al. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. , 1998, Blood.
[21] R. Mohammad,et al. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model. , 1996, Leukemia.
[22] J. Gabrilove,et al. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. , 1997, Blood.
[23] J. Reiffers,et al. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. , 2002, Carcinogenesis.
[24] A. Passaniti,et al. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. , 2001, Carcinogenesis.
[25] H. Matsuda,et al. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. , 2003, Bioorganic & medicinal chemistry.
[26] S. Pervaiz,et al. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. , 1998, Blood.
[27] Y. Pommier,et al. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. , 2003, Cancer research.
[28] A. Anichini,et al. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. , 2001, Cancer research.
[29] A. Hunter,et al. Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an ∼700 kDa Apaf-1 containing apoptosome complex , 2001, Leukemia.
[30] Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. , 2000, Carcinogenesis.
[31] D. L. Wilson,et al. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells , 2003, Leukemia.
[32] D. Dauzonne,et al. Synthesis and in vitro cytotoxicity of a series of 3-aminoflavones , 1997 .
[33] C. Croce,et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. , 1998, Blood.
[34] M. Nehls,et al. Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.
[35] N. Janakiraman,et al. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging , 2000, Bone Marrow Transplantation.
[36] M. Tsan,et al. Anti-leukemia Effect of Resveratrol , 2002, Leukemia & lymphoma.
[37] S. Mariotto,et al. Rapid Inactivation of NOS-I by Lipopolysaccharide Plus Interferon-γ-induced Tyrosine Phosphorylation* , 1999, The Journal of Biological Chemistry.
[38] T. Billiar,et al. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. , 1997, Biochemical and biophysical research communications.
[39] E. Mekada,et al. Characterization of Rat TOM40, a Central Component of the Preprotein Translocase of the Mitochondrial Outer Membrane* , 2000, The Journal of Biological Chemistry.
[40] A. Shah,et al. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. , 2000, Biochemical pharmacology.
[41] P. Groundwater,et al. Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. , 1992, Anti-cancer drug design.
[42] A. Senderowicz. Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies , 2001, Leukemia.
[43] R. Greil,et al. Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] C. Fegan,et al. Flavopiridol circumvents Bcl‐2 family mediated inhibition of apoptosis and drug resistance in B‐cell chronic lymphocytic leukaemia , 2001, British journal of haematology.
[45] B. Bauvois,et al. Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13. , 2003, Journal of medicinal chemistry.
[46] Daniel Schwartz,et al. Methodes Statistiques a L'Usage des Medecins et des Biologistes , 1964 .
[47] C. Reutelingsperger,et al. Expression on B Cells Undergoing Apoptosis Annexin V for Flow Cytometric Detection of Phosphatidylserine , 2022 .
[48] Weiya Ma,et al. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. , 1999, Carcinogenesis.